FendX Technologies Inc.

FendX has signed a collaboration agreement with Aquaox, formalizing the first phase of work from their Nov 2025 MOU. They’ll assess feasibility and formulation of new antimicrobial agents for potential future products, says CEO Dr. Carolyn Myers: fendxtech.com/news/

FendX is attending the 3rd Annual Dealflow Discovery Conference, January 28-29, 2026. CEO Carolyn Myers will deliver a presentation and meet one-on-one with investors to discuss recent progress, plans for 2026 and investment opportunities.

In partnership with FendX, Dr. Sara Imani, a post-doctoral fellow at McMaster University, has received the Mitacs Innovation Award for advancing an antimicrobial surface coating. LEARN MORE: eng.mcmaster.ca/mech/news/post…

FendX Technologies has signed an MOU with Aquaox to formulate eco-friendly pathogen-eliminating agents for FendX to develop new disinfectant products, expanding FendX’s pipeline and IP portfolio. NEWS RELEASE: fendxtech.com/news/ CSE: FNDX | OTCQB: FDXTF | FSE: E8D

FendX has filed a provisional patent with the USPTO for a catheter coating that reduces microbial growth and improves patient comfort, strengthening its portfolio of infection-reducing technologies.

Provisional patent for an AI-powered app to detect pathogens in real time using a mobile device has been filed by FendX CEO Dr. Carolyn Myers. NEWS RELEASE: fendxtech.com/news/ CSE: FNDX | OTCQB: FDXTF | FSE: E8D

“We are very encouraged by the continued successful performance of REPELWRAP™ film in real-world conditions,” said Dr. Carolyn Myers, our CEO. “These results support the promise of our technology, and we are now evaluating potential next steps in its development.”

FendX is featured in the June edition of the Canadian Securities Exchange Technology Issue! This spotlight highlights our innovative nanotechnology and the impact we’re making in the health and safety space. READ PAGES 28 TO 31: blog.thecse.com/canadian-secur…

FendX Technologies has hired a branding expert to help develop and market its new eco-friendly sponge line, targeting global consumer and commercial markets. NEWS RELEASE: fendxtech.com/news/ CSE: FNDX | OTCQB: FDXTF | FSE: E8D

FendX signs supply agreement with US BioSolutions for eco-friendly foam that is biodegradable, resistant to bacterial growth and free of toxic plasticizers to create various sponge products – tapping into a $1.96B North American household sponge market: fendxtech.com/news/

Update includes key milestones achieved since the last update, business development initiatives, and milestones planned for the remainder of 2025. NEWS RELEASE: fendxtech.com/news/

FendX’s CEO will deliver a corporate presentation on Wednesday, January 29 at 2:30 pm and engage in one-on-one meetings with institutional and individual investors to discuss the company’s recent developments, growth strategy & investment opportunities: fendxtech.com/news/

FendX signs LOI to acquire IP and enter a supply agreement for eco-friendly, reusable sponge wipes, offering a sustainable alternative to traditional surface cleaning sponges. NEWS RELEASE: fendxtech.com/news/

FendX Technologies has been granted its U.S. patent to protect REPELWRAP™ film, marking this its fifth patent issued, reinforcing FendX’s focus on building a robust IP portfolio. NEWS RELEASE: fendxtech.com/news/

FendX Technologies has entered into a Letter of Intent with Sinelabs LLC, aiming to establish a non-exclusive sales and distribution partnership for FendX’s future surface protection products in the U.S. market. NEWS RELEASE: fendxtech.com/news/

NEWS RELEASE: fendxtech.com/news/ CSE: FNDX | OTCQB: FDXTF | FSE: E8D #FendX #REPELWRAP #Nanotechnology

FendX was also a part of the Small Cap Growth Virtual Investor Conference, also hosted by the OTC Markets: proactiveinvestors.com/companies/news…

FendX Technologes Inc. announces successful completion of the pilot manufacturing phase and is now advancing to evaluate the repelling effectiveness of REPELWRAP™ film in real-world settings. NEWS RELEASE: fendxtech.com/press-releases/ CSE: FNDX | OTCQB: FDXTF | FSE: E8D

FendX Technologies Inc. is pleased to announce the publication of results from research conducted at McMaster University demonstrating that its AI-enhanced nanotechnology detects bacterial contamination at 96.7% accuracy on surfaces. NEWS RELEASE: fendxtech.com/press-releases/

FendX Technologies Inc. is pleased to have Dr. Ramchandani provide his extensive public health expertise to further FendX’s goal of advancing their innovative solutions for pathogen control and safety. NEWS RELEASE: fendxtech.com/press-releases/ CSE: FNDX | OTCQB: FDXTF | FSE: E8D